Skip to main content
Caplight Logo









Deepson Bio

Deepson Bio

Private
South KoreaHealthcare & Life Scienceshttps://deepsonbio.com/

Last Round

Pre A

Apr 14, 2025

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Deepson Bio is a medical technology company that develops therapeutic ultrasound devices intended to treat severe diseases and disorders.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical Imaging, Biotechnology, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

therapeutic ultrasoundmedical devicelow-intensity ultrasoundnon-invasive treatmentultrasound neuromodulationmedtechfocused ultrasoundM-LIPUSdrug delivery systemAlzheimer's treatmentcancer therapyclinical trialsbrain waste clearanceNormal Pressure HydrocephalusNPH

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Deepson Bio Comparables

Compare Deepson Bio with similar companies based on industry and business-model similarity.

Deepson Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Neurosona
86%
Ceretas
84%
Zhongke Green Valley (Shenzhen) Medical Technology Co., Ltd.
83%

Deepson Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Pre AApr 14, 2025

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 13, 2026

    Open job postings increased to 1 role, representing 33% of headcount.

  • Jun 21, 2026

    Monthly visitors increased 60% MoM.

Deepson Bio Filings

Explore SEC and related filing metadata, where available.

Deepson Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Deepson Bio's valuation, stock price, and market status.

Is Deepson Bio a public or private company?

Deepson Bio is a private company.

What is the current stock price of Deepson Bio?

Deepson Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Deepson Bio worth (valuation)?

Valuation information for Deepson Bio is not publicly available.

Can I buy Deepson Bio stock?

Deepson Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Deepson Bio's last funding round?

Funding round information for Deepson Bio is not publicly available.

Who are the main investors in Deepson Bio?

Investor information for Deepson Bio is not publicly disclosed.

Will Deepson Bio IPO soon?

No public IPO plans have been announced for Deepson Bio.

How can I track Deepson Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Deepson Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersSouth Korea
Employee Range3
Year Founded2018
Last FundingApr 14, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?